Xysmalorin

• CAT Number: I038494
• CAS Number: 31387-88-9
• Molecular Formula: C35H52O14
• Molecular Weight: 696.787
• Purity: 98%
• Synonyms: Xysmalorin
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• InChI: InChI=1S/C35H52O14/c1-33-8-5-18(46-32-30(28(42)26(40)23(14-37)48-32)49-31-29(43)27(41)25(39)22(13-36)47-31)12-17(33)3-4-21-20(33)6-9-34(2)19(7-10-35(21,34)44)16-11-24(38)45-15-16/h3,11,18-23,25-32,36-37,39-44H,4-10,12-15H2,1-2H3/t18-,19-,20-,21+,22+,23+,25+,26+,27-,28-,29+,30+,31-,32+,33+,34+,35+/m0/s1
• InChIKey: BPYRVOCFRMKMIP-LWTINOCQSA-N
• SMILES: O1[C@@H]([C@H]([C@H](O)[C@H]([C@@H]1O[C@H]1CC[C@@]2(C(C1)=CC[C@H]1[C@@]3(CC[C@@H](C4=CC(OC4)=O)[C@@]3(C)CC[C@H]21)O)C)O[C@H]1[C@H](O)[C@H]([C@@H]([C@H](O1)CO)O)O)O)CO

Xysmalorin (Cat No.: I038494) is an experimental compound under investigation for its potential therapeutic effects, particularly in the treatment of neurological and metabolic disorders. It is believed to work by targeting specific pathways involved in cell metabolism and signaling, potentially improving cellular function and reducing inflammation. Early preclinical studies suggest that Xysmalorin may have neuroprotective properties, offering potential benefits for conditions such as neurodegenerative diseases. Further research and clinical trials are ongoing to assess its safety, efficacy, and therapeutic potential in treating various health conditions.

Reference

1: Moteetee A, Seleteng Kose L. Medicinal plants used in Lesotho for treatment of reproductive and post reproductive problems. J Ethnopharmacol. 2016 Dec 24;194:827-849. doi: 10.1016/j.jep.2016.10.062. Epub 2016 Oct 22. PubMed PMID: 27780751.
2: Seleteng Kose L, Moteetee A, Van Vuuren S. Ethnobotanical survey of medicinal plants used in the Maseru district of Lesotho. J Ethnopharmacol. 2015 Jul 21;170:184-200. doi: 10.1016/j.jep.2015.04.047. Epub 2015 May 7. PubMed PMID: 25957810.
3: Vermaak I, Enslin GM, Idowu TO, Viljoen AM. Xysmalobium undulatum (uzara) – review of an antidiarrhoeal traditional medicine. J Ethnopharmacol. 2014 Oct 28;156:135-46. doi: 10.1016/j.jep.2014.08.016. Epub 2014 Sep 1. Review. PubMed PMID: 25193007.
4: Schmiedl S, Ritter A, Szymanski J, Schneider F, Plecko T, Alken RG, Thuermann PA. Cardiovascular effects, pharmacokinetics and cross-reactivity in digitalis glycoside immunoassays of an antidiarrheal uzara root extract. Int J Clin Pharmacol Ther. 2012 Oct;50(10):729-40. doi: 10.5414/CP201712. PubMed PMID: 22784612.
5: Ghorbani M, Kaloga M, Frey HH, Mayer G, Eich E. Phytochemical reinvestigation of Xysmalobium undulatum roots (Uzara). Planta Med. 1997 Aug;63(4):343-6. PubMed PMID: 17252392.